30006000330066003300660036007200
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)

30006000330066003300660036007200
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)
Lymphoma
The 2016 edition of the WHO added a new subtype of Burkitt-like lymphoma with an 11q abnormality, manifested by gain or loss of 11q, MYC translocation negativity. overexpression of PAFAH1B2 or deletion of the ETS1 gene. Children or young adults, more males than females. Morphology and phenotype very similar to Burkitt lymphoma (CD10+/BCL6+/BCL2-/high Ki67). Treatment options for Burkitt-like lymphoma with 11q abnormalities are similar to Burkitt lymphoma.